• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的血清铁动力学

The serum ferrokinetics in Parkinson's disease.

作者信息

Chen W H, Shih P Y

机构信息

Department of Neurology, Kaohsiung Medical College, Taiwan, Republic of China.

出版信息

Gaoxiong Yi Xue Ke Xue Za Zhi. 1992 Nov;8(11):581-4.

PMID:1296037
Abstract

Ferrous ion is an essential cofactor in dopamine synthesis and its decrease may reduce the dopamine production in the nigrostriatal system, the basis of pathogenetic mechanism in Parkinson's disease (PD). Therefore, parkinsonians may have an abnormal systemic ferrokinetics. The serum iron, ferritin, total-iron-binding-capacity (TIBC) levels and transferrin saturation were analysed in 15 patients with Parkinson's disease and 30 controls. The serum iron was lower in PD (95.53 +/- 33.5 micrograms/dl) than in controls (102.5 +/- 32.5 micrograms/dl), but the difference was statistically nonsignificant. The ferritin, TIBC and transferrin saturation were also similar in both groups. The systemic ferrokinetics in our PD was normal, but the ferrokinetics between the central and systemic compartments was different in PD. Therefore, reduction of central dopamine in PD is unlikely due to hypoferruginemia.

摘要

亚铁离子是多巴胺合成中必不可少的辅助因子,其减少可能会降低黑质纹状体系统中的多巴胺生成,而这正是帕金森病(PD)发病机制的基础。因此,帕金森病患者可能存在异常的全身铁动力学。对15例帕金森病患者和30名对照者的血清铁、铁蛋白、总铁结合力(TIBC)水平及转铁蛋白饱和度进行了分析。帕金森病患者的血清铁(95.53±33.5微克/分升)低于对照组(102.5±32.5微克/分升),但差异无统计学意义。两组的铁蛋白、TIBC和转铁蛋白饱和度也相似。我们研究中的帕金森病患者全身铁动力学正常,但帕金森病患者中枢和全身 compartments 之间的铁动力学不同。因此,帕金森病中中枢多巴胺的减少不太可能是由于低铁血症。

相似文献

1
The serum ferrokinetics in Parkinson's disease.帕金森病中的血清铁动力学
Gaoxiong Yi Xue Ke Xue Za Zhi. 1992 Nov;8(11):581-4.
2
Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.帕金森病中的铁与氧化应激:损伤生物标志物的观察性研究
PLoS One. 2016 Jan 11;11(1):e0146129. doi: 10.1371/journal.pone.0146129. eCollection 2016.
3
Altered systemic iron metabolism in Parkinson's disease.帕金森病中系统性铁代谢的改变。
Neurology. 1997 Sep;49(3):714-7. doi: 10.1212/wnl.49.3.714.
4
Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism.帕金森病患者较低的血红蛋白水平与疾病严重程度和铁代谢有关。
Brain Res. 2017 Jan 15;1655:145-151. doi: 10.1016/j.brainres.2016.11.007. Epub 2016 Nov 10.
5
Systemic iron metabolism and mortality from Parkinson's disease.全身铁代谢与帕金森病死亡率
Neurology. 1998 Apr;50(4):1138-40. doi: 10.1212/wnl.50.4.1138.
6
Dietary and serum iron, body iron stores and coronary heart disease.膳食铁与血清铁、机体铁储备及冠心病
J Assoc Physicians India. 2000 May;48(5):489-92.
7
Peripheral iron metabolism in patients with Parkinson's disease.帕金森病患者的外周铁代谢
J Neurol Sci. 1994 Aug;125(1):82-6. doi: 10.1016/0022-510x(94)90246-1.
8
Total iron binding capacity or transferrin concentration alone outperforms iron and saturation indices in predicting iron deficiency.单独的总铁结合力或转铁蛋白浓度在预测缺铁方面比铁和饱和度指标表现更优。
Clin Chim Acta. 2007 May 1;380(1-2):203-7. doi: 10.1016/j.cca.2007.02.032. Epub 2007 Feb 23.
9
Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk.触珠蛋白表型可改变血清铁水平以及吸烟对帕金森病风险的影响。
Parkinsonism Relat Disord. 2015 Sep;21(9):1087-92. doi: 10.1016/j.parkreldis.2015.07.006. Epub 2015 Jul 10.
10
Decreased ferritin levels in brain in Parkinson's disease.帕金森病患者大脑中铁蛋白水平降低。
J Neurochem. 1990 Jul;55(1):16-20. doi: 10.1111/j.1471-4159.1990.tb08814.x.